AVERY COLLINS: Open Payments
NPI 1144920281 · LITTLE ROCK, AR. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$2,332 in 140 payments from 13 companies in 2025. Trend: 2023 $1,727 · 2024 $1,973 · 2025 $2,332
Food & beverage: $1,967Education: $365
| Company | Payments | Amount |
|---|---|---|
| UCB, Inc. | 29 | $448 |
| Janssen Biotech, Inc. | 31 | $427 |
| Lilly USA, LLC | 26 | $365 |
| SUN PHARMACEUTICAL INDUSTRIES INC. | 11 | $326 |
| ABBVIE INC. | 13 | $160 |
| LEO Pharma Inc. | 12 | $145 |
| PFIZER INC. | 10 | $137 |
| Eli Lilly and Company | 1 | $99 |
| SANOFI-AVENTIS U.S. LLC | 1 | $90 |
| Regeneron Healthcare Solutions, Inc. | 2 | $52 |
Products named: TREMFYA, Bimzelx, TALTZ, ILUMYA, DUPIXENT, CIBINQO, SKYRIZI, ADBRY.
Industry payments across AR — which companies pay providers there.
